DAYSEE

• drugNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE78 co-mentions · 18 sources
• drugNORGESTIMATE AND ETHINYL ESTRADIOL73 co-mentions · 18 sources
• tagApproval62 co-mentions · 16 sources
• drugESTRING62 co-mentions · 18 sources
• tagSmall Molecule31 co-mentions · 16 sources
• drugnorethindrone16 co-mentions · 8 sources
• companyGlenmark Pharmaceuticals Ltd6 co-mentions · 1 sources
• companyLupin Ltd4 co-mentions · 2 sources

Trials studying DAYSEE

• phase1Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)recruitingn=24
• phase1A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesityrecruitingn=50
• phase1A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participantsrecruitingn=16
• phase1A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptivesactive not recruitingn=20
• phase1A Study of Elenestinib in Healthy Adult Female Participantscompletedn=20
• phase1Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)completedn=24
• phase1A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignanciesnot yet recruitingn=24
• phase1Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptivecompletedn=20